| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |